| CSPAX | OGICX | CSPAX / OGICX | |
| Total Expense Ratio | 1.04 | 1.90 | 55% |
| Annual Report Gross Expense Ratio | 1.04 | 1.90 | 55% |
| Fund Existence | 24 years | 32 years | - |
| Gain YTD | 4.763 | 4.306 | 111% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 82.4B | 2.28B | 3,620% |
| Annual Yield % from dividends | 0.67 | 0.00 | - |
| Returns for 1 year | 13.19 | 9.35 | 141% |
| Returns for 3 years | 24.19 | 3.68 | 658% |
| Returns for 5 years | -7.69 | -41.48 | 19% |
| Returns for 10 years | 103.16 | 21.00 | 491% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TFPN | 28.29 | 0.24 | +0.86% |
| Blueprint Chesapeake Multi-Asst Trnd ETF | |||
| ISCF | 44.31 | 0.26 | +0.59% |
| iShares MSCI Intl Small-Cap Mltfct ETF | |||
| XBI | 127.65 | 0.30 | +0.24% |
| State Street® SPDR® S&P® Biotech ETF | |||
| GPRF | 50.78 | N/A | N/A |
| Goldman Sachs Acs US Pref Stk &HySecETF | |||
| QRFT | 62.82 | -0.63 | -0.99% |
| QRAFT AI-Enhanced US Large Cap ETF | |||